Miller to Receive American Cancer Society's Cancer Control Award
PHILADELPHIA (September 27, 2002) -- Suzanne M. Miller, Ph.D., director of Fox Chase Cancer Center's psychosocial and behavioral medicine program, has been selected to receive the distinguished Cancer Control Award from the American Cancer Society (ACS) for her contributions to cancer prevention and control. The award will be presented October 29 during the ACS Pennsylvania Division's awards celebration at the Adam's Mark Hotel in Philadelphia.
A resident of Montgomery Township in Princeton, N.J., Miller has combined her skills as a clinical psychologist to advance the field of behavioral oncology. Her unique approach focuses on tailoring information about cancer risk and management for specific populations to make groundbreaking cancer technologies more accessible. Her work has included identifying and addressing people's barriers to behavior change, such as smoking cessation; participating in cancer-prevention and clinical trials; and following recommended screening guidelines.
Miller has received national and international recognition for her work, which has a special focus on underserved groups. She has designed and implemented cancer-prevention and control programs for minority populations in such areas as cervical, breast, ovarian, prostate and lung cancer. After receiving a B.S. from McGill University in 1972, Miller earned her Ph.D. in clinical psychology at the University of London's Institute of Psychiatry in 1976. Since the late 1970s, she has been extremely interested in the interface of psychology and medicine and has published and lectured widely in this area.
She also holds a number of adjunct professorships, including positions in the department of psychiatry at the University of Pennsylvania, the department of obstetrics and gynecology at Temple University, the Fels Institute for Cancer Research and Molecular Biology at Temple University and the Institute for Health, Health Care Policy, and Aging Research at Rutgers University.
Miller has been honored as a distinguished visiting professor across the globe in places such as Italy, Switzerland, Japan and the Netherlands.
To support her noteworthy research, Miller has received several grants from the National Cancer Institute as well as funding from the American Cancer Society, the National Institutes of Mental Health, the National Human Genome Research Institute, and the United States Department of Defense.
In addition to her numerous honors and professional involvements, in 2000 Miller founded the Behavioral Oncology Interest Group within the American Society for Preventive Oncology to advance knowledge across the spectrum of cancer control.
Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at www.fccc.edu.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.